by TGAR Foundation | Sep 7, 2022 | General
Windi Muziasari PhD. Resistomap CEO. While antibiotic resistance is associated with 4,95 million deaths in 2019 and it will cost the global economy approximately 1-6% of the global GDP by 2050, it is also one of the six emerging environmental pollutants of concern...
by TGAR Foundation | Aug 16, 2022 | General
Björn Rönnerstrand Dr. in political science and researcher at the SOM Institute, University Gothenborg Sweden. Data from Transparency International show that corruption (defined as “abuse of entrusted power for private gain”) is widespread globally. Moreover,...
by TGAR Foundation | Aug 10, 2022 | General
Pekka Honkanen Prof. em. MD. Professor Emiritus of Oulu University and still practizing MD in Terveystalo Antimicrobial stewardship can be passive or active. Passive intervention consists of evidence-based guidelines, education of clinical staff, development of...
by TGAR Foundation | Jun 30, 2022 | General
Ville Kainu MD. PhD. Global Medical Affairs Director, Anti-Infectives Pfizer How to incentivize research and development A few years ago, the WHO developed a priority list of bacteria against which new antibiotics are needed, ranging from critical to medium priority....
by TGAR Foundation | Jun 9, 2022 | General
Eero Punkka Dr. Director of the Helsinki Biobank The Helsinki Biobank, founded by the Helsinki University Hospital (HUS) and Helsinki University, is the largest hospital biobank in Finland. It serves an area which comprises 40% of the Finnish population. When...
